바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.71 No.2
Citation Share

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2011, v.71 no.2, pp.114-119








& (2011). . Tuberculosis & Respiratory Diseases, 71(2), 114-119.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: There is very limited data present on smoking cessation rates in outpatient departments of pulmonology. In this study, we aimed to investigate the effectiveness of a brief smoking cessation intervention program in an outpatient department of pulmonology and identify predictors of smoking cessation failure. Methods: After a brief recommendation of smoking cessation from pulmonologists, smokers willing to quit smoking were given individual counseling and supplement drugs. Fifty smokers were included in this study and baseline characteristics, smoking history and success rate were reviewed at 3 months. Results: The mean age of the patients was 58.3±14.6 years and the total group of patients included 3 women. The rate of smoking cessation success was 74% at 3 months, and there were no differences in age, spirometric indexes and associated diseases between the smoking cessation success and failure group. The rate of supplement drug usage was not different in both groups either. However, body weight, mean number of cigarette usage per day and nicotine dependence scores in the failure group were significantly higher than in the success group. In multivariate analysis, body weight and mean number of cigarette usage per day were significant. Two smokers with a depressive disorder failed the smoking cessation. Conclusion: A smoking cessation intervention program in the outpatient department of pulmonology showed a favorable success rate. More intensive interventions are needed to unfavorable groups which include the obese and heavy smokers.

keywords
Smoking Cessation, Outpatients, Smoking Cessation, Outpatients

Reference

1.

1. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009;360:699-709.

2.

2. Fiore MC, McCarthy DE, Jackson TC, Zehner ME, Jorenby DE, Mielke M, et al. Integrating smoking cessation treatment into primary care: an effectiveness study. Prev Med 2004;38:412-20.

3.

3. Kim YH, Lee SH. Smoking cessation. Tuberc Respir Dis 2010;69:153-62.

4.

4. Kim MH. Updates in smoking cessation programs. Korean J Health Psychol 2005;10:259-76.

5.

5. Goodfellow LT, Waugh JB. Tobacco treatment and prevention: what works and why. Respir Care 2009;54: 1082-90.

6.

6. Cheong YS, Ahn SH. Effect of multi-modal interventions for smoking cessation in a university setting: a short course of varenicline, financial incentives, e-mail and short message service. Korean J Fam Med 2010;31:355-60.

7.

7. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.

8.

8. Andreas S, Hering T, Mühlig S, Nowak D, Raupach T, Worth H. Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention. Dtsch Arztebl Int 2009;106:276-82.

9.

9. Seo NS, Kim YH, Kang HY. The effects of a group smoking cessation program among adult smokers in a rural community. J Korean Acad Nurs 2007;37:1139-48.

10.

10. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained- release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296: 47-55.

11.

11. Pohlig C. Smoking cessation counseling: a practice management perspective. Chest 2006;130:1231-3.

12.

12. Bars MP, Banauch GI, Appel D, Andreachi M, Mouren P, Kelly KJ, et al. "Tobacco free with FDNY": the New York City Fire Department World Trade Center tobacco cessation study. Chest 2006;129:979-87.

13.

13. Hotta K, Kinumi K, Naito K, Kuroki K, Sakane H, Imai A, et al. An intensive group therapy programme for smoking cessation using nicotine patch and internet mailing supports in a university setting. Int J Clin Pract 2007;61:1997-2001.

14.

14. Rennard SI, Daughton DM. Smoking cessation. Chest 2000;117(5 Suppl 2):S360-4.

15.

15. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA 1994; 271:589-94.

16.

16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991;86:1119-27.

17.

17. Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, et al. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Intern Med 2004;140:426-33.

18.

18. Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 1988;259:2863-6.

19.

19. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA 1990; 264:1541-5.

20.

20. Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav 2001;15:13-7.

21.

21. Kim TS, Kim DJ. The association between smoking and depression. Korean J Psychopharmacol 2007;18:393-8.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy